PT Kalbe Farma Tbk. (IDX:KLBF)

Indonesia flag Indonesia · Delayed Price · Currency is IDR
1,135.00
+35.00 (3.18%)
Mar 27, 2025, 4:10 PM WIB
-24.58%
Market Cap 52.38T
Revenue (ttm) 32.13T
Net Income (ttm) 3.08T
Shares Out 46.15B
EPS (ttm) 66.79
PE Ratio 16.99
Forward PE 15.65
Dividend 31.00 (2.73%)
Ex-Dividend Date May 29, 2024
Volume 49,328,700
Average Volume 63,862,705
Open 1,100.00
Previous Close 1,100.00
Day's Range 1,085.00 - 1,135.00
52-Week Range 985.00 - 1,795.00
Beta 0.15
RSI 50.92
Earnings Date Mar 27, 2025

About PT Kalbe Farma Tbk.

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products. It operates Mitrasana Clinics, a health care service. In addition, the comp... [Read more]

Sector Healthcare
Founded 1966
Employees 13,108
Stock Exchange Indonesia Stock Exchange
Ticker Symbol KLBF
Full Company Profile

Financial Performance

In 2023, PT Kalbe Farma Tbk.'s revenue was 30.45 trillion, an increase of 5.24% compared to the previous year's 28.93 trillion. Earnings were 2.77 trillion, a decrease of -18.20%.

Financial Statements

News

There is no news available yet.